Carol Farver
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Carol Farver has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Arnold Culver
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic, Cleveland, Ohio, USA
2 shared publications M. Askar
2 shared publicationsM. Budev
2 shared publicationsA. Bharat
1 shared publicationA. Zhang
1 shared publicationA.V. Arrossi
Department of Pathology, Pathology and Laboratory Medicine Institute, Cleveland, Ohio, United States
1 shared publication
Latest Publications
- Open Access
- 13 February 2026
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 12 (3) , e1904
A Whole-body Cooling Strategy in Uncontrolled Donation After Circulatory Death: Insights From a Porcine Ex Vivo Lung Perfusion Model
Background.: Prolonged warm ischemia in uncontrolled donation after circulatory death (uDCD) potentially increases the risk of graft dysfunction in lung transplantation. To address this concern, a noninvasive, whole-body cooling approach was developed using a specialized liquid refrigerant at −21 °C. The aim of this study was to investigate whether this method reduces lung temperature and improves lung function in uDCD donors. Methods.: Fifteen pigs were randomly assigned to 3 groups. In the study group (n = 5), the entire donor body was submerged in a basin containing a coolant of −21 °C, and chest compression was performed during 90 min of warm ischemia. In the sham group (n = 5), neither body cooling nor chest compression was performed during 90 min of warm ischemia. Lungs were evaluated by cellular ex vivo lung perfusion (EVLP) after 5 h of additional cold ischemia. Lungs in the donation after brain death (DBD) group (n = 5) were perfused after 1 h of cold ischemia. Results.: Tracheal temperature decreased to 28.5 °C in the study group and remained at 38.1 °C in the sham group. Lungs in the study group showed higher transplant suitability with significantly higher PaO 2 /FiO 2 , and lower peak inspiratory pressure during EVLP than those in the sham group (all P < 0.05). The study group had a significantly higher ATP level, a relatively lower hypoxia-inducible factor-1α level, and lower percentage of apoptotic cells than the sham group. Conclusions.: This novel cooling approach effectively reduced lung temperature during warm ischemia, resulting in improved lung function during EVLP. These data suggest that this method could mitigate ischemia–reperfusion injury in uDCD donors, expanding the donor lung pool.
- 13 February 2026
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 12 (3) , e1904
Open AccessA Whole-body Cooling Strategy in Uncontrolled Donation After Circulatory Death: Insights From a Porcine Ex Vivo Lung Perfusion Model
Background.: Prolonged warm ischemia in uncontrolled donation after circulatory death (uDCD) potentially increases the risk of graft dysfunction in lung transplantation. To address this concern, a noninvasive, whole-body cooling approach was developed using a specialized liquid refrigerant at −21 °C. The aim of this study was to investigate whether this method reduces lung temperature and improves lung function in uDCD donors. Methods.: Fifteen pigs were randomly assigned to 3 groups. In the study group (n = 5), the entire donor body was submerged in a basin containing a coolant of −21 °C, and chest compression was performed during 90 min of warm ischemia. In the sham group (n = 5), neither body cooling nor chest compression was performed during 90 min of warm ischemia. Lungs were evaluated by cellular ex vivo lung perfusion (EVLP) after 5 h of additional cold ischemia. Lungs in the donation after brain death (DBD) group (n = 5) were perfused after 1 h of cold ischemia. Results.: Tracheal temperature decreased to 28.5 °C in the study group and remained at 38.1 °C in the sham group. Lungs in the study group showed higher transplant suitability with significantly higher PaO 2 /FiO 2 , and lower peak inspiratory pressure during EVLP than those in the sham group (all P < 0.05). The study group had a significantly higher ATP level, a relatively lower hypoxia-inducible factor-1α level, and lower percentage of apoptotic cells than the sham group. Conclusions.: This novel cooling approach effectively reduced lung temperature during warm ischemia, resulting in improved lung function during EVLP. These data suggest that this method could mitigate ischemia–reperfusion injury in uDCD donors, expanding the donor lung pool.
- 23 November 2024
- Published by Springer Nature in Virchows Archiv
- Vol. 487 (1) , 47-59
Clinical and histopathological features of immune checkpoint inhibitor-induced lung toxicity
A new era in cancer therapy emerged with the arrival of immune-checkpoint inhibitors (ICIs), followed by a new cadre of immune-related adverse events that affect up to 40% of patients. Literature on the pathological features associated with these events is still limited. Therefore, to expand our knowledge of the histopathologic spectrum of pulmonary changes, we conducted a case study series analysis on 16 non-neoplastic lung samples collected during or after ICI therapy. A set of predefined histological features related to the four different “compartments” (interstitium, pneumocyte, alveolar space, and bronchial mucosa), the CD4/CD8 T cell ratio, and the SP263 PD-L1 expression in the immune cells was assessed in three study categories [ICI + radiotherapy with/without chemotherapy (RT-based), ICI + chemotherapy (CT-based), ICI-based monotherapy (ICI-mono)]. Our results identified interstitial thickening, interstitial lymphocytic infiltrate, pneumocyte desquamation, intra-alveolar fibrin, or foamy macrophages in at least half of the cases in each of the study categories; all five features were present in 4 (RT-based), 3 (CT-based) and 1 (ICI-mono) patients. Hyaline membrane was a frequent finding in CT-based (80%) and ICI-mono (100%) compared to RT-based (44%) category. Moreover, CD4/CD8 ratio was ≤ 1 for almost all cases of the three study categories. Finally, a positive SP263 PD-L1 expression was identified in 50% or more of each study category. In conclusion, our results indicate that histopathologic findings in patients treated with ICI therapy are not diagnostic and varied. Additionally, these results are in line with recent studies showing an expansion on CD8+ T cell subset in patients under ICI treatment and highlight the synergism of polytherapy.
- 23 November 2024
- Published by Springer Nature in Virchows Archiv
- Vol. 487 (1) , 47-59
Clinical and histopathological features of immune checkpoint inhibitor-induced lung toxicity
A new era in cancer therapy emerged with the arrival of immune-checkpoint inhibitors (ICIs), followed by a new cadre of immune-related adverse events that affect up to 40% of patients. Literature on the pathological features associated with these events is still limited. Therefore, to expand our knowledge of the histopathologic spectrum of pulmonary changes, we conducted a case study series analysis on 16 non-neoplastic lung samples collected during or after ICI therapy. A set of predefined histological features related to the four different “compartments” (interstitium, pneumocyte, alveolar space, and bronchial mucosa), the CD4/CD8 T cell ratio, and the SP263 PD-L1 expression in the immune cells was assessed in three study categories [ICI + radiotherapy with/without chemotherapy (RT-based), ICI + chemotherapy (CT-based), ICI-based monotherapy (ICI-mono)]. Our results identified interstitial thickening, interstitial lymphocytic infiltrate, pneumocyte desquamation, intra-alveolar fibrin, or foamy macrophages in at least half of the cases in each of the study categories; all five features were present in 4 (RT-based), 3 (CT-based) and 1 (ICI-mono) patients. Hyaline membrane was a frequent finding in CT-based (80%) and ICI-mono (100%) compared to RT-based (44%) category. Moreover, CD4/CD8 ratio was ≤ 1 for almost all cases of the three study categories. Finally, a positive SP263 PD-L1 expression was identified in 50% or more of each study category. In conclusion, our results indicate that histopathologic findings in patients treated with ICI therapy are not diagnostic and varied. Additionally, these results are in line with recent studies showing an expansion on CD8+ T cell subset in patients under ICI treatment and highlight the synergism of polytherapy.
- Open Access
- 21 January 2019
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 19 (1) , 20
A single-institution study of concordance of pathological diagnoses for interstitial lung diseases between pre-transplantation surgical lung biopsies and lung explants
By comparing diagnoses made by pre-transplant surgical lung biopsy (SLB) and the final pathologic diagnosis of the explanted pathology (EP), we aimed to study the factors that could impact pathologic diagnoses in patients with interstitial lung disease (ILD). We retrospectively reviewed the lung transplant database at Cleveland Clinic [01/01/2006–12/31/2013] to include all lung transplant recipients with a prior diagnosis of ILD. Two pulmonary pathologists independently reviewed each SLB and lung explant. The diagnoses were labeled as concordant (same diagnosis on SLB and explant) or discordant (diagnosis on SLB and explant were different) by consensus. Of 389 patients transplanted for ILD, 217 had an SLB before transplant. Pathological diagnoses were concordant in 190 patients (87.6%) [165 UIP (86.8%), 13 NSIP (6.8%), 8 CHP (4.2%) and 4 other diagnoses (2.1%). In 27 cases (12.4%), the diagnosis on SLB differed from EP. 8/27 were diagnosed with UIP on SLB and of these, 5 were re-classified as NSIP. 14/19 (73.7%) patients with a SLB diagnosis “other than UIP” were re-categorized as UIP based on explant. Discordant cases had a greater time between SLB and EP than concordant cases (1553 days vs 1248 days). The pathologic diagnosis of ILD by SLB prior to lung transplant is accurate in most patients, but may be misleading in a small subset of patients. The majority of discordant cases that were reclassified as UIP could be due to a sampling error, or perhaps, an increased time from the date of the SLB to transplant. Future studies examining how multidisciplinary consensus diagnosis affects this discordance are necessary.
- 21 January 2019
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 19 (1) , 20
Open AccessA single-institution study of concordance of pathological diagnoses for interstitial lung diseases between pre-transplantation surgical lung biopsies and lung explants
By comparing diagnoses made by pre-transplant surgical lung biopsy (SLB) and the final pathologic diagnosis of the explanted pathology (EP), we aimed to study the factors that could impact pathologic diagnoses in patients with interstitial lung disease (ILD). We retrospectively reviewed the lung transplant database at Cleveland Clinic [01/01/2006–12/31/2013] to include all lung transplant recipients with a prior diagnosis of ILD. Two pulmonary pathologists independently reviewed each SLB and lung explant. The diagnoses were labeled as concordant (same diagnosis on SLB and explant) or discordant (diagnosis on SLB and explant were different) by consensus. Of 389 patients transplanted for ILD, 217 had an SLB before transplant. Pathological diagnoses were concordant in 190 patients (87.6%) [165 UIP (86.8%), 13 NSIP (6.8%), 8 CHP (4.2%) and 4 other diagnoses (2.1%). In 27 cases (12.4%), the diagnosis on SLB differed from EP. 8/27 were diagnosed with UIP on SLB and of these, 5 were re-classified as NSIP. 14/19 (73.7%) patients with a SLB diagnosis “other than UIP” were re-categorized as UIP based on explant. Discordant cases had a greater time between SLB and EP than concordant cases (1553 days vs 1248 days). The pathologic diagnosis of ILD by SLB prior to lung transplant is accurate in most patients, but may be misleading in a small subset of patients. The majority of discordant cases that were reclassified as UIP could be due to a sampling error, or perhaps, an increased time from the date of the SLB to transplant. Future studies examining how multidisciplinary consensus diagnosis affects this discordance are necessary.
- 15 February 2018
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 197 (4) , 541-542
Reply to Fernandez-Bussy et al. : Recurrent Respiratory Papillomatosis and Bevacizumab Treatment
- 15 February 2018
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 197 (4) , 541-542
Reply to Fernandez-Bussy et al. : Recurrent Respiratory Papillomatosis and Bevacizumab Treatment
- 15 February 2018
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 197 (4) , 522-524
Delayed Alveolar Epithelialization: A Distinct Pathology in Diffuse Acute Lung Injury
- 15 February 2018
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 197 (4) , 522-524
Delayed Alveolar Epithelialization: A Distinct Pathology in Diffuse Acute Lung Injury
- 1 January 2018
- Published by Elsevier in Transplantation Proceedings
- Vol. 50 (1) , 234-240
Unexpected Neoplasms in Lungs Explanted From Lung Transplant Recipients: A Single-Center Experience and Review of Literature
- 1 January 2018
- Published by Elsevier in Transplantation Proceedings
- Vol. 50 (1) , 234-240
Unexpected Neoplasms in Lungs Explanted From Lung Transplant Recipients: A Single-Center Experience and Review of Literature
- Open Access
- 22 February 2016
- Published by Scientific Scholar in Cytojournal
- Vol. 13 (1) , 4
Fine needle aspiration biopsy of metastatic malignant mesothelioma with myxoid change and signet ring cells: A case report and review of the literature
Malignant mesothelioma (MM) is a rare neoplasm, which is most commonly encountered in cytology through effusion specimens. Fine needle aspiration biopsy of MM, particularly the epithelioid subtype, can be a source of diagnostic difficulty and may mimic sampling of an adenocarcinoma. This is the first case report to demonstrate abundant extracellular myxoid material and numerous intracellular vacuoles, including signet ring cells, in a fine needle aspirate of metastatic MM. A review of the literature for myxoid change and vacuoles in fine needle aspiration biopsies of MM discloses that vacuoles are found in up to 35% of aspirates of MM, but myxoid change is very rare, reported in
- 22 February 2016
- Published by Scientific Scholar in Cytojournal
- Vol. 13 (1) , 4
Open AccessFine needle aspiration biopsy of metastatic malignant mesothelioma with myxoid change and signet ring cells: A case report and review of the literature
Malignant mesothelioma (MM) is a rare neoplasm, which is most commonly encountered in cytology through effusion specimens. Fine needle aspiration biopsy of MM, particularly the epithelioid subtype, can be a source of diagnostic difficulty and may mimic sampling of an adenocarcinoma. This is the first case report to demonstrate abundant extracellular myxoid material and numerous intracellular vacuoles, including signet ring cells, in a fine needle aspirate of metastatic MM. A review of the literature for myxoid change and vacuoles in fine needle aspiration biopsies of MM discloses that vacuoles are found in up to 35% of aspirates of MM, but myxoid change is very rare, reported in
- 1 January 2016
- Published by Springer Nature
- p. 1353-1402
Lung and Pleura
- 1 June 2015
- Published by Elsevier in Annals of Diagnostic Pathology
- Vol. 19 (3) , 149-153
Pulmonary capillary hemangiomatosis associated with connective tissue disease: a report of 4 cases and review of the literature
- 1 June 2015
- Published by Elsevier in Annals of Diagnostic Pathology
- Vol. 19 (3) , 149-153
Pulmonary capillary hemangiomatosis associated with connective tissue disease: a report of 4 cases and review of the literature
- 1 April 2015
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 34 (4) , S19
Autoantibodies Against Lung Tissue Can Cause Hyper Acute as Well as Acute Antibody Mediated Rejection Following Lung Transplantation
- 1 April 2015
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 34 (4) , S19
Autoantibodies Against Lung Tissue Can Cause Hyper Acute as Well as Acute Antibody Mediated Rejection Following Lung Transplantation